Shawver Laura, Director of ARS Pharmaceuticals SPRY, has filed 0 purchases and 23 sales on the open market. The latest trade was on 06/24.

SL

SL

Shawver Laura

Director

Company

ARS Pharmaceuticals SPRY

First filing

23/05/10

Trades

82 trades

Buys / sales

0 / 23

12-month net buying

No record

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	25/04/07	25/04/08	50,002 sh	$12.30	$615,024.6	−19.2%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	25/03/05–25/03/06	25/03/07	50,000 sh2 trades	$11.21avg.	$560,416	−19.2%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	25/02/03	25/02/04	50,000 sh	$12.31	$615,500	−19.2%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	25/01/06	25/01/07	50,000 sh	$11.10	$555,000	−19.2%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	24/12/02–24/12/04	24/12/04	200,000 sh4 trades	$13.44avg.	$2,688,150.83	−48.7%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	23/09/01	23/09/05	100,000 sh	$7.71	$771,000	−32.2%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	23/08/03–23/08/04	23/08/07	45,004 sh2 trades	$7.03avg.	$316,422.89	−17.6%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	23/08/01–23/08/02	23/08/03	54,996 sh2 trades	$7.12avg.	$391,793.14	−20.7%
ARS PharmaceuticalsSPRY	Open-market sale	23/07/07	23/07/07	8,858 sh	$6.36	$56,336.88	−4.0%
ARS PharmaceuticalsSPRY	Open-market sale	23/07/03–23/07/06	23/07/06	91,142 sh3 trades	$6.48avg.	$590,360.92	−30.2%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	23/06/01–23/06/02	23/06/02	100,000 sh2 trades	$6.84avg.	$684,041.15	−32.2%
ARS PharmaceuticalsSPRY	Open-market sale10b5-1 plan	22/11/09–23/05/09	23/05/10	143,896 sh3 trades	$5.42avg.	$780,578.68	−40.6%